These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26984957)

  • 21. Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.
    Corvillo F; Bravo García-Morato M; Nozal P; Garrido S; Tortajada A; Rodríguez de Córdoba S; López-Trascasa M
    Clin Exp Immunol; 2016 Apr; 184(1):118-25. PubMed ID: 26660535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction.
    Habersberger J; Strang F; Scheichl A; Htun N; Bassler N; Merivirta RM; Diehl P; Krippner G; Meikle P; Eisenhardt SU; Meredith I; Peter K
    Cardiovasc Res; 2012 Oct; 96(1):64-72. PubMed ID: 22798388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properdin binds independent of complement activation in an in vivo model of anti-glomerular basement membrane disease.
    O'Flynn J; Kotimaa J; Faber-Krol R; Koekkoek K; Klar-Mohamad N; Koudijs A; Schwaeble WJ; Stover C; Daha MR; van Kooten C
    Kidney Int; 2018 Dec; 94(6):1141-1150. PubMed ID: 30322716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The many effects of complement C3- and C5-binding proteins in renal injury.
    Puri TS; Quigg RJ
    Semin Nephrol; 2007 May; 27(3):321-37. PubMed ID: 17533009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease.
    Ma R; Cui Z; Hu SY; Jia XY; Yang R; Zheng X; Ao J; Liu G; Liao YH; Zhao MH
    PLoS One; 2014; 9(3):e91250. PubMed ID: 24658070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three pentraxins C-reactive protein, serum amyloid p component and pentraxin 3 mediate complement activation using Collectin CL-P1.
    Roy N; Ohtani K; Hidaka Y; Amano Y; Matsuda Y; Mori K; Hwang I; Inoue N; Wakamiya N
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):1-14. PubMed ID: 27864148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
    Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
    Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.
    Sissons JG; Oldstone MB; Schreiber RD
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):559-62. PubMed ID: 6928644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement.
    Zhang J; Song L; Pedersen DV; Li A; Lambris JD; Andersen GR; Mollnes TE; Ma YJ; Garred P
    Elife; 2020 Sep; 9():. PubMed ID: 32909942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).
    Ji SR; Wu Y; Zhu L; Potempa LA; Sheng FL; Lu W; Zhao J
    FASEB J; 2007 Jan; 21(1):284-94. PubMed ID: 17116742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity.
    Karlsson J; Wetterö J; Weiner M; Rönnelid J; Fernandez-Botran R; Sjöwall C
    Arthritis Res Ther; 2022 Jun; 24(1):139. PubMed ID: 35690780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury.
    Thiele JR; Zeller J; Kiefer J; Braig D; Kreuzaler S; Lenz Y; Potempa LA; Grahammer F; Huber TB; Huber-Lang M; Bannasch H; Stark GB; Peter K; Eisenhardt SU
    Front Immunol; 2018; 9():675. PubMed ID: 29713320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
    Mold C; Nemerow GR; Bradt BM; Cooper NR
    J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properdin binding to complement activating surfaces depends on initial C3b deposition.
    Harboe M; Johnson C; Nymo S; Ekholt K; Schjalm C; Lindstad JK; Pharo A; Hellerud BC; Nilsson Ekdahl K; Mollnes TE; Nilsson PH
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E534-E539. PubMed ID: 28069958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tubular staining of modified C-reactive protein in diabetic chronic kidney disease.
    Schwedler SB; Guderian F; Dämmrich J; Potempa LA; Wanner C
    Nephrol Dial Transplant; 2003 Nov; 18(11):2300-7. PubMed ID: 14551357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein enhances activation of coagulation system and inflammatory response through dissociating into monomeric form in antineutrophil cytoplasmic antibody-associated vasculitis.
    Xu PC; Lin S; Yang XW; Gu DM; Yan TK; Wei L; Wang BL
    BMC Immunol; 2015 Mar; 16():10. PubMed ID: 25879749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.
    Agarwal S; Specht CA; Haibin H; Ostroff GR; Ram S; Rice PA; Levitz SM
    mBio; 2011; 2(5):. PubMed ID: 21878570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predominant role for C5b-9 in renal ischemia/reperfusion injury.
    Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH
    J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.